Evaluation of Pulmonary Functions in Recovered Patient's of COVID-19 Pneumonitis: A Prospective Study
Authors/Creators
- 1. PG Resident, Department of Respiratory Medicine, Pacific Institute of Medical Sciences, Umarda, Ambua Road, Udaipur, Rajasthan-313003, India
- 2. Assistant Professor, Department of Respiratory Medicine, Pacific Institute of Medical Sciences, Umarda, Ambua Road, Udaipur, Rajasthan-313003, India
- 3. Associate Professor, Department of Pathology, Hind Institute of Medical sciences, Sitapur, Uttar Pradesh-261303, India
Description
Introduction: Every year, respiratory illnesses claim the lives of almost 7 million individuals around the world. Many viruses are to blame for these epidemics. One of the infections is COVID-19, a developing infection brought on by the coronavirus 2 virus that causes acute respiratory syndrome (SARS-CoV-2). Aim and Objectives: To assess the pulmonary functions in COVID-19pneumonitis recovered patients. Methodology: With approval from the institutional ethical committee and review board and written informed patient consent, the study was carried out at the Department of Respiratory Medicine, Pacific Institute of Medical Sciences, Umarda, Udaipur. Result: COVID-19 pneumonitis patients were categorised by onset of symptoms as mild(19.44%), moderate(48.14%) & severe(32.40%). CT scan severity score was found as mild(1-8), moderate(9-15) & severe (>15) considered as (45.37%), (48.14%) & (06.48%) COVID-19 pneumonitis patients respectively. Pulmonary function examination, it was found that FEV1(L), FVC(L), FVC(% Predicted), FEV1/FVC (%), TLC and DLCO were statistically significant between Severe and non-severe COVID-19 Pneumonitis patients respectively. (p<0.05). Conclusion: Even though the pulmonary dysfunction brought on by the SARS-CoV-2 infection got better over time, the affected patients didn’t fully recover after being released. Several COVID-19 patients experienced pulmonary dysfunction and abnormal lung CT results after recovering, with imaging abnormalities happening more frequently in severe individuals.
Abstract (English)
Introduction: Every year, respiratory illnesses claim the lives of almost 7 million individuals around the world. Many viruses are to blame for these epidemics. One of the infections is COVID-19, a developing infection brought on by the coronavirus 2 virus that causes acute respiratory syndrome (SARS-CoV-2). Aim and Objectives: To assess the pulmonary functions in COVID-19pneumonitis recovered patients. Methodology: With approval from the institutional ethical committee and review board and written informed patient consent, the study was carried out at the Department of Respiratory Medicine, Pacific Institute of Medical Sciences, Umarda, Udaipur. Result: COVID-19 pneumonitis patients were categorised by onset of symptoms as mild(19.44%), moderate(48.14%) & severe(32.40%). CT scan severity score was found as mild(1-8), moderate(9-15) & severe (>15) considered as (45.37%), (48.14%) & (06.48%) COVID-19 pneumonitis patients respectively. Pulmonary function examination, it was found that FEV1(L), FVC(L), FVC(% Predicted), FEV1/FVC (%), TLC and DLCO were statistically significant between Severe and non-severe COVID-19 Pneumonitis patients respectively. (p<0.05). Conclusion: Even though the pulmonary dysfunction brought on by the SARS-CoV-2 infection got better over time, the affected patients didn’t fully recover after being released. Several COVID-19 patients experienced pulmonary dysfunction and abnormal lung CT results after recovering, with imaging abnormalities happening more frequently in severe individuals.
Files
IJPCR,Vol15,Issue7,Article118.pdf
Files
(346.7 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:41859a020c272a03523c814d010a91d1
|
346.7 kB | Preview Download |
Additional details
Dates
- Accepted
-
2023-05-25
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/15/IJPCR,Vol15,Issue7,Article118.pdf
- Development Status
- Active
References
- 1. Zumla A, Niederman MS. The explosive epidemic outbreak of novel coronavirus disease 2019 (COVID-19) and the persistent threat of respiratory tract infectious diseases to global health security. Curr opin pulm med. 2020; 10.1097/MCP. 2. Farnoosh G, Alishiri G, Hosseini Zijoud S, Dorostkar R, Jalali Farahani A. Understanding the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease (COVID-19) Based on Available Evidence - A Narrative Review. J Mil Med. 2020; 22:1-11. 3. Hemati S, Mobini GR, Heidari M, Rahmani F, Soleymani Babadi A, Farhadkhani M, et al. Simultaneous monitoring of SARS-CoV-2, bacteria, and fungi in indoor air of hospital: a study on Hajar Hospital in Shahrekord, Iran. Environ Sci Pollut Res Int. 2021; 28:43792- 802. 4. Chia PY, Coleman KK, Tan YK, Ong SWX, Gum M, Lau SK, et al. Detection of air and surface contamination by severe, acute respiratory syndrome coronavirus 2 (SARSCoV-2) in hospital rooms of infected patients. MedRxiv 2020.5. Xie J, Covassin N, Fan Z, Singh P, Gao W, Li G, et al. Association between hypoxemia and mortality in patients with COVID-19. Mayo Clin Proc. 2020; 95:1138-47. 6. Repici A, Maselli R, Colombo M, Gabbiadini R, Spadaccini M, Anderloni A, et al. Coronavirus (COVID-19) outbreak: what the department of endoscopy should know. Gastrointest endosc. 2020; 92:192-7. 7. Jayaweera M, Perera H, Gunawardana B, Manatunge J. Transmission of COVID-19 virus by droplets and aerosols: A critical review on the unresolved dichotomy. Environ Res. 2020; 188:109819. 8. Torres-Castro R, Vasconcello-Castillo L, Alsina-Restoy X, Solis-Navarro L, Burgos F, Puppo H, et al. Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysis. Pulmonology. 2021; 27:328-37. 9. Sharifian A, Sigari N, Rahimi E, Yazhdanpanah K. Survey of normal indices of pulmonary function test by use of spirometry in the people of Kurdistan province. Sci J Kurdistan Uni Med Sci. 2007; 12:1-8. 10. Liu N, He G, Yang X, Chen J, Wu J, Ma M, Lu W, Li Q, Cheng T, Huang X. Dynamic changes of chest CT follow-up in coronavirus disease19 (COVID-19) pneumonia: relationship to clinical typing. BMC Medical Imaging. 2020;20(1):1-8. 11. Huang Y, Tan C, Wu J, Chen M, Wang Z, Luo L, Zhou X, Liu X, Huang X, Yuan S, Chen C. Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase. Respiratory research. 2020 Dec;21(1):1-0 12. Lv D, Chen X, Mao L, Sun J, Wu G, Lin Z, Lin R, Yu J, Wu X, Jiang Y. Pulmonary function of patients with 2019 novel coronavirus induced pneumonia: a retrospective cohort study. Ann Palliat Med 2020;9(5):3447-3452 13. Karoli R, Gupta N, Shakya S. Follow-up Study of Pulmonary Function, Exercise Capacity and Radiological Changes after Recovery from Moderate to Severe COVID Pneumonia without Mechanical Ventilation. The Journal of the Association of Physicians of India. 2022 Dec 1;69(12):11-2. 14. Babadi AS, Kashefizadeh A, Dalili N, Ohadi L, Gheisoori A, Kazemizadeh H. Evaluation of the pulmonary function test (Pft) in patients affected by severe covid-19 pneumonia: 6 to 12 weeks after discharge. Acta Medica Iranica. 2021;59(11):669. 15. Liu N, He G, Yang X, Chen J, Wu J, Ma M, Lu W, Li Q, Cheng T, Huang X. Dynamic changes of chest CT follow-up in coronavirus disease19 (COVID-19) pneumonia: relationship to clinical typing. BMC Medical Imaging. 2020;20(1):1-8. 16. Yu C, Hu XY, Zou C, Yu FF, Liu B, Li Y, Liu Y, Song LJ, Tan L, Li Q, Hu YC. Associations between severe pulmonary function and residual CT abnormalities in rehabilitating COVID19 patients. European Review for Medical and Pharmacological Sciences. 2021 Dec 1;25(23):7585-97. 17. Guler SA, Ebner L, Aubry-Beigelman C, Bridevaux PO, Brutsche M, Clarenbach C, Garzoni C, Geiser TK, Lenoir A, Mancinetti M, Naccini B. Pulmonary function and radiological features 4 months after COVID-19: first results from the national perspective observational Swiss COVID-19 lung study. European respiratory journal. 2021 Apr 1;57(4). 18. Zhong L, Zhang S, Wang J, Zhao X, Wang K, Ding W, Xing Z, Shen J. Analysis of chest CT results of coronavirus disease 2019 (COVID19) patients at first follow-up. Canadian Respiratory Journal. 2020 Nov 1;2020. 19. Polese J, Sant'Ana L, Moulaz IR, Lara IC, Bernardi JM, Lima MD, Turini EA, Silveira GC, Duarte S, Mill JG. Pulmonary function evaluation after hospital discharge of patients with severe COVID-19. Clinics. 2021 Jun 28;76. 20. Anastasio F, Barbuto S, Scarnecchia E, Cosma P, Fugagnoli A, Rossi G, Parravicini M, Parravicini P. Medium-term impact of COVID-19 on pulmonary function, functional capacity and quality of life. European Respiratory Journal. 2021 Sep 1;58(3). 21. Wu Q, Zhong L, Li H, Guo J, Li Y, Hou X, Yang F, Xie Y, Li L, Xing Z. A follow-up study of lung function and chest computed tomography at 6 months after discharge in patients with coronavirus disease 2019. Canadian respiratory journal. 2021 Feb 13;2021. 22. Karoli R, Gupta N, Shakya S. Follow-up Study of Pulmonary Function, Exercise Capacity and Radiological Changes after Recovery from Moderate to Severe COVID Pneumonia without Mechanical Ventilation. The Journal of the Association of Physicians of India. 2022 Dec 1;69(12):11-2. 23. Zhou F, Tao M, Shang L, Liu Y, Pan G, Jin Y, Wang L, Hu S, Li J, Zhang M, Fu Y. Assessment of sequelae of COVID-19 nearly 1 year after diagnosis. Frontiers in Medicine. 2021;8. 24. Eksombatchai D, Wongsinin T, Phongnarudech T, Thammavaranucupt K, Amornputtisathaporn N, Sungkanuparph S. Pulmonary function and six-minute-walk test in patients after recovery from COVID-19: A prospective cohort study. PloSone. 2021 Sep 2;16(9): e0257040.